ICU Medical Incorporated (ICUI) reported quarterly earnings results on Monday, Aug-8-2016. The company said it had a profit of $1.15 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.10. Analysts had a consensus of $1.05. The company posted revenue of $96.72 million in the period, compared to analysts expectations of $89.66 million. The company’s revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.97 EPS.
ICU Medical Incorporated opened for trading at $116.4 and hit $118.31 on the upside on Friday, eventually ending the session at $117.49, with a gain of 1.05% or 1.22 points. The heightened volatility saw the trading volume jump to 68,004 shares. Company has a market cap of $1,889 M.
In a different news, on Jul 29, 2016, Joseph R Saucedo (director) sold 2,000 shares at $115.47 per share price. According to the SEC, on Jun 29, 2016, Steven Riggs (VP Operations) sold 20,000 shares at $110.00 per share price. On May 9, 2016, Robert S Swinney (director) sold 1,875 shares at $101.40 per share price, according to the Form-4 filing with the securities and exchange commission.
ICU Medical Inc. is engaged in the development manufacturing and sales of medical devices used in infusion therapy oncology and critical care applications. The Companys product line includes needlefree connection devices custom infusion sets closed system transfer devices (CSTD) for the handling of hazardous drugs advanced sensor catheters needlefree closed blood sampling systems disposable pressure transducer systems and innovative hemodynamic monitoring systems. The Companys products are used in acute care hospitals and ambulatory clinics in more than 60 countries worldwide. Its products are categorized into three market segments: Infusion Therapy Critical Care and Oncology. Its primary products include MicroClave and MicroClave Clear Anti-Microbial MicroClave Tego needlefree hemodialysis connector Transpac disposable pressure transducers Pulmonary artery thermodilution catheters ChemoLock CSTD and components and Diana hazardous drug compounding system among others.